Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Nextmune in connection with its acquisition of I.C.F. S.r.l and D.R.N. S.r.l.
Mandate

Vinge advised Nextmune in connection with its acquisition of I.C.F. S.r.l and D.R.N. S.r.l.

October 08, 2020 Banking and Finance M&A

Vinge has advised Fidelio Capital and its portfolio company Nextmune, a leading science driven, global specialty pharmaceutical company dedicated to improving health for dogs, cats and horses, in connection with its acquisition of I.C.F. S.r.l and D.R.N. S.r.l.

Vinge’s team consisted of, among others, Jonas Bergström, Matthias Pannier, Maria Dahlin-Kolvik, Karl Klackenberg, Manne Bergström, Vilhelm Rondahl and Albert Wållgren, Josefine Lanker, Axel Jansson och Jolinn Uhlin.

Related

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

 Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

 Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026

Vinge advises Morrow Bank in connection with cross-border merger and list change from Oslo Børs to Nasdaq Stockholm

 Vinge has advised Morrow Bank in connection with its reverse cross-border merger, whereby Morrow Bank AB is taking over Morrow Bank ASA. The Norwegian bank was previously listed on the Oslo Stock Exchange which was today transferred to Nasdaq Stockholm. Vinge has previously assisted Morrow Bank in obtaining a Swedish banking licence.
January 12, 2026